Cite
HARVARD Citation
Coleman, C. et al. (n.d.). Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1. European heart journal. 5 (2), pp. 64-69. [Online].